Exor N.V. 13F: Quarter-over-Quarter Portfolio Changes
Exor N.V. reported a disclosed portfolio value of approximately $5.5 billion in its latest SEC Form 13F-HR filing for Q2 2026, up 1.4% quarter on quarter. Over the quarter, the family office bought more shares in 1 holding.
Exor N.V.'s top buy was Koninklijke Philips N V (SYN_000000000) . The family office bought 1.9% more shares, lifting the position's portfolio weight by -0.3 percentage points.
Top BuysQ2 2026
The family office's top buys among existing positions in Q2 2026. Ranked by portfolio-weight impact, with the percentage of additional shares shown separately.
| Company | Ticker | Portfolio Weight Change | More Shares | History |
|---|---|---|---|---|
| KONINKLIJKE PHILIPS N V | SYN_000000000 | +-0.3% | +1.9% | Holders → |
Net Portfolio Value ChangeQ2 2026
- $5.4BPrior quarter
- $5.5BCurrent quarter
- +$0.1BNet delta
- +1.4%% change
Methodology & FAQ
How Exor N.V. Quarterly Changes Are Computed
All deltas are sourced from sequential SEC Form 13F-HR filings for Exor N.V.: each row joins the most recent filing against the immediately preceding quarterly filing for the same fund. Share-count changes reflect reported trading activity, while portfolio weights can also move because of market price changes. Portfolio weights are normalized to exclude listed options for comparability. A complete description, including how confidential treatment filings are handled, is documented in the Methodology.
What stocks did Exor N.V. buy in Q2 2026?
In Q2 2026, Exor N.V. bought more shares of KONINKLIJKE PHILIPS N V (SYN_000000000).
What stocks did Exor N.V. sell in Q2 2026?
Exor N.V. reported no full exits or share-count reductions in its Q2 2026 13F filing.
Which positions did Exor N.V. initiate in Q2 2026?
Exor N.V. established no new positions in Q2 2026.
Which existing positions saw the largest allocation increases for Exor N.V. in Q2 2026?
Of 1 existing position with share-count increases in Q2 2026, the largest were: KONINKLIJKE PHILIPS N V (SYN_000000000, +-0.3% weight, +1.9% shares).
Which positions did Exor N.V. fully exit in Q2 2026?
Exor N.V. fully exited no positions in Q2 2026.
Which existing positions saw the largest allocation reductions for Exor N.V. in Q2 2026?
Exor N.V. reported no material allocation reductions in existing positions in Q2 2026.
Do quarter-over-quarter 13F allocation changes constitute explicit trading signals?
No. Quarter-over-quarter changes reflect a combination of active trading and market price movement. A weight increase can result from price appreciation alone, without the manager adding shares. Share-count delta is the cleaner indicator of explicit trading activity. All deltas on this page are sourced from sequential SEC Form 13F-HR filings.